Curcumin and Dimethoxycurcumin Induced Epigenetic Changes in Leukemia Cells

被引:32
作者
Hassan, Hazem E. [1 ]
Carlson, Samuel [2 ]
Abdallah, Inas [1 ]
Buttolph, Thomm [3 ]
Glass, Karen C. [2 ]
Fandy, Tamer E. [2 ]
机构
[1] Univ Maryland, Dept Pharmaceut Sci, Baltimore, MD 21201 USA
[2] Albany Coll Pharm, Dept Pharmaceut Sci, Colchester, VT 05446 USA
[3] Univ Vermont, Dept Neurol Sci, Burlington, VT USA
关键词
curcumin; dimethoxycurcumin; DNA methylation; DNA pyrosequencing; histone methylation; DNA METHYLTRANSFERASE INHIBITORS; BREAST-CANCER CELLS; HYPOMETHYLATION AGENT; HISTONE DEACETYLASE; PANCREATIC-CANCER; GENE-EXPRESSION; CYCLE ARREST; KAPPA-B; ANALOGS; METHYLATION;
D O I
10.1007/s11095-014-1502-4
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Curcumin is an ideal chemopreventive and antitumor agent characterized by poor bioavailability and low stability. The development of synthetic structural analogues like dimethoxycurcumin (DMC) could overcome these drawbacks. In this study we compared the cytotoxicity, metabolism and the epigenetic changes induced by both drugs in leukemia cells. Apoptosis and cell cycle analysis were analyzed by flow cytometry. Real-time PCR was used for gene expression analysis. DNA methylation was analyzed by DNA pyrosequencing. The metabolic stability was determined using human pooled liver microsomes. Chromatin Immunoprecipitation was used to quantify histone methylation. Clinically relevant concentration of curcumin and DMC were not cytotoxic to leukemia cells and induced G2/M cell cycle arrest. DMC was more metabolically stable than curcumin. Curcumin and DMC were devoid of DNA hypomethylating activity. DMC induced the expression of promoter methylated genes without reversing DNA methylation and increased H3K36me3 mark near the promoter region of hypermethylated genes. DMC is a more stable analogue of curcumin that can induce epigenetic changes not induced by curcumin. DMC induced the expression of promoter methylated genes. The combination of DMC with DNA methyltransferase inhibitors could harness their combined induced epigenetic changes for optimal re-expression of epigenetically silenced genes.
引用
收藏
页码:863 / 875
页数:13
相关论文
共 43 条
[1]   Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases [J].
Brueckner, B ;
Boy, RG ;
Siedlecki, P ;
Musch, T ;
Kliem, HC ;
Zielenkiewicz, P ;
Suhai, S ;
Wiessler, M ;
Lyko, F .
CANCER RESEARCH, 2005, 65 (14) :6305-6311
[2]   Current Prospects of Synthetic Curcumin Analogs and Chalcone Derivatives Against Mycobacterium Tuberculosis [J].
Bukhari, Syed Nasir Abbas ;
Franzblau, Scott G. ;
Jantan, Ibrahim ;
Jasamai, Malina .
MEDICINAL CHEMISTRY, 2013, 9 (07) :897-903
[3]   Stable and Potent Analogues Derived from the Modification of the Dicarbonyl Moiety of Curcumin [J].
Chakraborti, Soumyananda ;
Dhar, Gopa ;
Dwivedi, Vishnu ;
Das, Amlan ;
Poddar, Asim ;
Chakraborti, Gopal ;
Basu, Gautam ;
Chakrabarti, Pinak ;
Surolia, Avadhesha ;
Bhattacharyya, Bhabatarak .
BIOCHEMISTRY, 2013, 52 (42) :7449-7460
[4]   C086, a novel analog of curcumin, induces growth inhibition and downregulation of NFκB in colon cancer cells and xenograft tumors [J].
Chen, Chun ;
Liu, Yang ;
Chen, Yuanzhong ;
Xu, Jianhua .
CANCER BIOLOGY & THERAPY, 2011, 12 (09) :797-807
[5]   Curcumin and its analogues as potent inhibitors of low density lipoprotein oxidation: H-atom abstraction from the phenolic groups and possible involvement of the 4-hydroxy-3-methoxyphenyl groups [J].
Chen, WF ;
Deng, SL ;
Zhou, B ;
Yang, L ;
Liu, ZL .
FREE RADICAL BIOLOGY AND MEDICINE, 2006, 40 (03) :526-535
[6]   Curcumin, both histone deacetylase and p300/CBP-Specific inhibitor, represses the activity of nuclear factor kappa B and Notch 1 in Raji cells [J].
Chen, Yan ;
Shu, Wenxiu ;
Chen, Weihua ;
Wu, Qing ;
Liu, Hongli ;
Cui, Guohui .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 101 (06) :427-433
[7]   Reactivation of RASSF1A in Breast Cancer Cells by Curcumin [J].
Du, Liping ;
Xie, Zhiliang ;
Wu, Lai-chu ;
Chiu, Ming ;
Lin, Jiayuh ;
Chan, Kenneth K. ;
Liu, Shujun ;
Liu, Zhongfa .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2012, 64 (08) :1228-1235
[8]   Replication-independent chromatin loading of Dnmt1 during G2 and M phases [J].
Easwaran, HP ;
Schermelleh, L ;
Leonhardt, H ;
Cardoso, MC .
EMBO REPORTS, 2004, 5 (12) :1181-1186
[9]   Decitabine Induces Delayed Reactive Oxygen Species (ROS) Accumulation in Leukemia Cells and Induces the Expression of ROS Generating Enzymes [J].
Fandy, Tamer E. ;
Jiemjit, Anchalee ;
Thakar, Manjusha ;
Rhoden, Paulette ;
Suarez, Lauren ;
Gore, Steven D. .
CLINICAL CANCER RESEARCH, 2014, 20 (05) :1249-1258
[10]   Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies [J].
Fandy, Tamer E. ;
Herman, James G. ;
Kerns, Patrick ;
Jiemjit, Anchalee ;
Sugar, Elizabeth A. ;
Choi, Si-Ho ;
Yang, Allen S. ;
Aucott, Timothy ;
Dauses, Tianna ;
Odchimar-Reissig, Rosalie ;
Licht, Jonathan ;
McConnell, Melanie J. ;
Nasrallah, Chris ;
Kim, Marianne K. H. ;
Zhang, Weijia ;
Sun, Yezou ;
Murgo, Anthony ;
Espinoza-Delgado, Igor ;
Oteiza, Katharine ;
Owoeye, Ibitayo ;
Silverman, Lewis R. ;
Gore, Steven D. ;
Carraway, Hetty E. .
BLOOD, 2009, 114 (13) :2764-2773